GlassScriptPhysician profile
Joyce A Addo
NPI 1871881920
$2,684.67
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,731 · 2022: $903 · 2024: $50.03.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $50.03.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $50.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $423.64 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $373.37 | 2021-2022 | |
| Amarin Pharma, INC. | $357.86 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $339.84 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $238.37 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $215.60 | 2021-2022 | |
| Arbor Pharmaceuticals, INC. | $167.07 | 2021 | |
| Esperion Therapeutics, INC. | $130.19 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $103.10 | 2022 | |
| Astellas Pharma US INC | $102.75 | 2022 | |
| Merck Sharp & Dohme LLC | $96.51 | 2021-2022 | |
| Boston Scientific Corporation | $50.03 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $35.95 | 2022 | |
| Biosense Webster, INC. | $27.11 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $23.28 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joyce Addo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.